Previous Close | 937.61 |
Open | 926.94 |
Bid | 865.45 x 200 |
Ask | 1,020.33 x 200 |
Day's Range | 926.94 - 947.08 |
52 Week Range | 684.81 - 998.33 |
Volume | |
Avg. Volume | 472,833 |
Market Cap | 103.458B |
Beta (5Y Monthly) | 0.14 |
PE Ratio (TTM) | 27.00 |
EPS (TTM) | 34.77 |
Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1,053.08 |
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Regeneron Pharmaceuticals ( NASDAQ:REGN ) First Quarter 2024 Results Key Financial Results Revenue: US$3.15b (flat on...
Discover how Regeneron sustains robust growth with significant advancements in clinical programs and strategic market maneuvers.